This inventor holds 2 USPTO granted patents and 5 published patent applications. Top assignees: Genzyme Corporation, Sionna Therapeutics Inc.. Active years: 2026.
Company Filing History:
2 out of 823 
2 out of 2 Years Active: 2026
Title: David Borcherding: Innovator in Pharmaceutical Compounds
Introduction
David Borcherding is a notable inventor based in Bangor, PA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of macrocyclic compounds. With a total of 2 patents, his work has the potential to impact various therapeutic areas.
Latest Patents
Borcherding's latest patents include innovative formulations and methods related to CFTR modulators. These patents encompass pharmaceutical compositions and methods of making and using these compounds. His research focuses on enhancing the efficacy of treatments through novel macrocyclic compounds.
Career Highlights
Throughout his career, David Borcherding has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Genzyme Corporation and Sionna Therapeutics Inc. His experience in these organizations has contributed to his expertise in drug development and innovation.
Collaborations
David has collaborated with various professionals in his field, including his coworker Michael Kothe. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in pharmaceutical research.
Conclusion
David Borcherding's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as an innovator. His work continues to pave the way for advancements in drug development and therapeutic solutions.